CIK 0001781983
- Non-accelerated filer
- Smaller reporting company
Aprea Therapeutics, Inc.
Sign in to watch- Ticker
- APRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 215-948-4119
- Business address
- 3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-04-09 | Versant V Luxco S.a r.l. 10% owner | Other acquisition | +2,210,937 | 2,210,937 | ||
| 2020-04-09 | Versant V Luxco S.a r.l. 10% owner | Other acquisition | +66,506 | 66,506 | ||
| 2020-04-09 | Versant V Luxco S.a r.l. 10% owner | Other acquisition | +73,617 | 73,617 | ||
| 2020-04-09 | Versant V Luxco S.a r.l. 10% owner | Other acquisition | +168,263 | 168,263 | ||
| 2020-03-24 | SCHADE CHRISTIAN S President & CEO | Grant or award · Stock Option (right to Buy) | +127,000 | 127,000 | ||
| 2020-03-24 | Korbel Gregory Alan VP of Business Dev't | Grant or award · Stock Option (right to Buy) | +12,800 | 12,800 | ||
| 2020-03-24 | Attar Eyal C. SVP, Chief Medical Officer | Grant or award · Stock Option (right to Buy) | +55,000 | 55,000 | ||
| 2020-03-24 | Abrahmsen Lars B. SVP, Chief Scientific Officer | Grant or award · Stock Option (right to Buy) | +31,600 | 31,600 | ||
| 2020-03-24 | Coiante Scott M SVP, Chief Financial Officer | Grant or award · Stock Option (right to Buy) | +55,000 | 55,000 | ||
| 2019-10-07 | 5AM Ventures IV, L.P. 10% owner | Conversion | +1,913,910 | 1,926,073 | ||
| 2019-10-07 | 5AM Ventures IV, L.P. 10% owner | Conversion | +79,746 | 80,253 | ||
| 2019-10-07 | 5AM Ventures IV, L.P. 10% owner | Conversion | +492,475 | 2,418,548 | ||
| 2019-10-07 | 5AM Ventures IV, L.P. 10% owner | Conversion | +20,519 | 100,772 | ||
| 2019-10-07 | 5AM Ventures IV, L.P. 10% owner | Purchase | +333,333 | $15.00 | $5.0M | 333,333 |
| 2019-10-07 | 5AM Ventures IV, L.P. 10% owner | Conversion · Series B Convertible Preferred Stock | −1,913,910 | 0 | ||
| 2019-10-07 | 5AM Ventures IV, L.P. 10% owner | Conversion · Series B Convertible Preferred Stock | −79,746 | 0 | ||
| 2019-10-07 | 5AM Ventures IV, L.P. 10% owner | Conversion · Series C Convertible Preferred Stock | −492,475 | 0 | ||
| 2019-10-07 | 5AM Ventures IV, L.P. 10% owner | Conversion · Series C Convertible Preferred Stock | −20,519 | 0 | ||
| 2019-10-07 | Redmile Group, LLC 10% owner | Conversion | +1,868,718 | 1,868,718 | ||
| 2019-10-07 | Redmile Group, LLC 10% owner | Purchase | +400,000 | $15.00 | $6.0M | 2,268,718 |
Page 14 of 17 · 334 trades